Soheil Haddadzadegan | Pharmocology | Most Cited Article Award

Most Cited Article Award

Soheil Haddadzadegan
Affiliation Nanyang Technological University
Country Singapore
Scopus ID 57408006400
ORCID 0000-0002-8979-864X
Documents 21
Citations 975
h-index 13
Subject Area Pharmacology
Event International Research Excellence and Best Paper Awards

Soheil Haddadzadegan — Nanyang Technological University

Soheil Haddadzadegan of Nanyang Technological University, Singapore, is recognized in this Most Cited Article Award profile for research in Pharmacology. The recognized article, “Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers,” examines lipid-based nanocarrier technologies developed to address the challenges associated with the oral administration of therapeutic peptides and proteins.[1]

Abstract

This article presents Soheil Haddadzadegan in connection with the Most Cited Article Award for research in Pharmacology. The recognized publication examines the technology landscape of lipid-based nanocarriers for the oral delivery of therapeutic peptides and proteins. Because biological macromolecules can face substantial barriers during oral administration, lipid-based delivery systems have been investigated as potential platforms for improving protection, transport, absorption, and bioavailability. The article provides a technology-focused perspective on the development of lipid-based nanocarriers for oral peptide and protein delivery and highlights their relevance to pharmaceutical formulation and drug-delivery research.[1]

Keywords

Most Cited Article Award, Soheil Haddadzadegan, Pharmacology, Oral Drug Delivery, Therapeutic Peptides, Therapeutic Proteins, Lipid-Based Nanocarriers, Nanomedicine, Drug Delivery Systems, Pharmaceutical Technology, Oral Peptide Delivery, Protein Delivery, Bioavailability, Lipid Nanoparticles, Nanocarriers, Drug Formulation.[1]

Introduction

The oral delivery of therapeutic peptides and proteins represents an important challenge in pharmaceutical science because these molecules may experience degradation, limited permeability, and inefficient absorption within the gastrointestinal environment. Lipid-based nanocarriers have emerged as a technological approach for addressing some of these limitations by providing protective delivery environments and opportunities for improved transport across biological barriers. The recognized article examines the broader technology landscape surrounding lipid-based nanocarriers and their application to oral peptide and protein delivery.[1]

Research Profile

Soheil Haddadzadegan is affiliated with Nanyang Technological University in Singapore and is associated with research in Pharmacology. According to the supplied Scopus profile information, the researcher has 21 documents, 975 citations, and an h-index of 13. The Scopus Author ID associated with this profile is 57408006400. The researcher is also identified through ORCID record 0000-0002-8979-864X, providing a persistent identifier for distinguishing and connecting scholarly contributions across research systems.[2][3]

Research Contributions

The recognized research focuses on lipid-based nanocarriers as technological platforms for the oral administration of therapeutic peptides and proteins. Such delivery systems are investigated for their potential to protect sensitive biological molecules from adverse gastrointestinal conditions while supporting their transport and absorption. By examining the technology landscape, the publication contributes to understanding the formulation strategies, delivery challenges, and development opportunities associated with lipid-based systems for macromolecular therapeutics.[1]

Publication

The principal publication associated with this award profile is “Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.” The article addresses the development and technological landscape of lipid-based nanocarriers for oral delivery of peptide and protein therapeutics and is recognized here for its substantial scholarly citation impact in the field of Pharmacology.[1]

Research Impact

The research has demonstrated substantial scholarly visibility, with the supplied Scopus profile reporting 975 citations across 21 documents and an h-index of 13. The recognized article addresses a significant pharmaceutical delivery challenge and provides a technology-oriented perspective on lipid-based nanocarriers for therapeutic peptides and proteins. Its citation performance reflects continued scholarly interest in oral macromolecular drug delivery and nanocarrier-based pharmaceutical technologies.[1][2]

Award Recognition

Soheil Haddadzadegan is recognized in this Most Cited Article Award profile for the scholarly contribution represented by “Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.” The recognition highlights the article’s strong citation impact and its relevance to the development of advanced oral drug-delivery technologies for therapeutic peptides and proteins. The award profile acknowledges the publication’s contribution to Pharmacology and pharmaceutical nanotechnology research.[1][2]

Conclusion

Soheil Haddadzadegan of Nanyang Technological University, Singapore, is featured in this Most Cited Article Award profile for research in Pharmacology. The recognized publication explores the technology landscape of lipid-based nanocarriers for oral delivery of therapeutic peptides and proteins, addressing important challenges associated with the administration of biological therapeutics. With 975 citations, 21 documents, and an h-index of 13 according to the supplied Scopus information, the researcher demonstrates a notable scholarly impact within the research profile presented here.[1][2]

External Links

References

  1. Haddadzadegan, S. “Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.”
    https://pubmed.ncbi.nlm.nih.gov/34999121/
  2. Scopus. (n.d.). Scopus Author Profile: Soheil Haddadzadegan.
    https://www.scopus.com/authid/detail.uri?authorId=57408006400
  3. ORCID. (n.d.). ORCID Profile: Soheil Haddadzadegan.
    https://orcid.org/0000-0002-8979-864X
  4. Best Paper Awards. (n.d.).
    https://bestpaperawards.com/

Pradeep Kumar | Pharmacology, Toxicology and Pharmaceutical Science | Best Paper Award

Best Paper Award

Insights into the Biological Activities and Substituent Effects of Pyrrole Derivatives: The Chemistry-Biology Connection.
Pradeep Kumar
Affiliation KLE College of Pharmacy, Hubli
Country India
Article Title Insights into the Biological Activities and Substituent Effects of Pyrrole Derivatives: The Chemistry-Biology Connection
Scopus ID 57206689423
Article Type Review Article
Article Views 713
Reference Count 105
Award Category Best Paper Award
Event International Research Excellence and Best Paper Awards
ORCID 0000-0003-4033-8877

Pradeep Kumar, affiliated with KLE College of Pharmacy, Hubli, India, has been recognized under the Best Paper Award category for the scholarly article titled “Insights into the Biological Activities and Substituent Effects of Pyrrole Derivatives: The Chemistry-Biology Connection”. Published in 2024 through Wiley Online Library, the article presents a comprehensive review of pyrrole derivatives, emphasizing their pharmacological relevance, structure–activity relationships, and the influence of chemical substituents on biological performance. The work contributes to medicinal chemistry by integrating chemical and biological perspectives into a unified scientific framework.[1]

Abstract

This review article examines the chemistry and biological significance of pyrrole derivatives, a class of heterocyclic compounds widely investigated in medicinal chemistry. The study discusses structural modifications, substituent effects, and their influence on pharmacological properties including antimicrobial, anticancer, anti-inflammatory, antioxidant, and antiviral activities. Particular attention is given to structure–activity relationships that guide the rational design of bioactive molecules. By consolidating findings from diverse studies, the review highlights emerging trends, therapeutic opportunities, and future directions for pyrrole-based drug discovery. The article serves as a valuable scientific resource for researchers exploring innovative medicinal applications of pyrrole-containing compounds.[2]

Keywords

Pyrrole derivatives; Medicinal chemistry; Structure–activity relationship; Drug discovery; Heterocyclic compounds; Biological activity; Substituent effects; Pharmacological properties.

Introduction

Pyrrole derivatives occupy an important position in pharmaceutical and medicinal chemistry because of their presence in numerous natural products, therapeutic agents, and biologically active molecules. Understanding how chemical modifications affect biological activity remains essential for designing safer and more effective drug candidates. The reviewed article addresses this challenge by examining the relationship between molecular structure and pharmacological performance across diverse pyrrole-based compounds.[2]

Research Profile

Pradeep Kumar is associated with KLE College of Pharmacy, Hubli, India. His academic interests include medicinal chemistry, pharmaceutical sciences, heterocyclic chemistry, and bioactive molecular design. Through scholarly publications and scientific investigations, he has contributed to advancing knowledge regarding the therapeutic potential of chemically modified compounds and their applications in modern drug development.[1]

Scientific Background

Heterocyclic compounds constitute a significant proportion of approved pharmaceuticals. Pyrrole-containing molecules are especially important because their electronic properties and structural flexibility facilitate interactions with biological targets. Previous research has demonstrated that subtle substituent changes can significantly alter potency, selectivity, and pharmacokinetic characteristics. Consequently, comprehensive evaluations of substituent effects are essential for understanding molecular behavior and optimizing therapeutic outcomes.[3]

Methodology

The article adopts a systematic review-based methodology by collecting, analyzing, and synthesizing published scientific literature related to pyrrole derivatives. Research findings from medicinal chemistry, pharmacology, and drug discovery studies were comparatively evaluated to identify recurring structure–activity relationships. The approach enables comprehensive assessment of biological activities while providing an integrated understanding of how molecular substitutions influence pharmacological responses.[2]

Key Findings

The review demonstrates that biological activity in pyrrole derivatives is strongly influenced by substituent type, position, and electronic characteristics. Specific structural modifications were associated with improved antimicrobial, anticancer, antioxidant, and anti-inflammatory effects. The study further identifies molecular patterns that may enhance target specificity and therapeutic efficacy. These observations provide valuable guidance for future medicinal chemistry programs seeking optimized pyrrole-based drug candidates.[2]

Scientific Contributions

A major contribution of this article is the consolidation of extensive evidence regarding pyrrole derivative bioactivity into a single scholarly resource. The review provides a structured interpretation of substituent effects, facilitating better understanding of molecular design strategies. Its interdisciplinary perspective bridges chemistry and biology, supporting researchers involved in drug discovery, pharmacological evaluation, and rational therapeutic development.[4]

Conclusion

The recognized article provides a comprehensive examination of pyrrole derivatives and their diverse biological activities. By highlighting the influence of structural modifications on pharmacological behavior, the study contributes meaningful insights to medicinal chemistry research. Its synthesis of current scientific knowledge offers practical guidance for future investigations aimed at developing effective pyrrole-based therapeutic agents and expanding the understanding of chemistry–biology relationships.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Pradeep Kumar, Author ID 57206689423. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57206689423
  2. Kumar, P. (2024). Insights into the Biological Activities and Substituent Effects of Pyrrole Derivatives: The Chemistry-Biology Connection. Chemistry & Biodiversity.
    DOI: https://doi.org/10.1002/cbdv.202400534
  3. Wiley Online Library. (2024). Article abstract and publication information.
    https://onlinelibrary.wiley.com/doi/abs/10.1002/cbdv.202400534
  4. Wiley Online Library. (2024). Chemistry & Biodiversity Journal.
    https://onlinelibrary.wiley.com/journal/16121880/
  5. International Research Excellence and Best Paper Awards. (2026). Best Paper Award Recognition Program.
    https://bestpaperawards.com/

Dr. Kakali Purkayastha | Pharmacology | Research Excellence Award

Dr. Kakali Purkayastha | Pharmacology | Research Excellence Award

Consultant | ICMR HeadQuarters | India

Dr. Kakali Purkayastha is a researcher known for contributions to interdisciplinary scientific studies, with a professional record spanning academic and applied research environments. Her professional experience includes collaborative projects, publications, and mentoring roles that reflect scholarly engagement. Her research interests focus on scientific domains, emphasizing innovation and practical impact. She possesses research skills in data analysis, experimental design, and scientific communication. Her awards and honors recognize excellence and dedication to research advancement. Overall, her work demonstrates commitment to knowledge development and impactful scholarship. She has achieved 98 Citations, 4 Documents, 4 h-index.

Citation Metrics (Scopus)

100
50
0

98
Citations

4
Documents

4
h-index

Citations

Documents

h-index

View Scopus Profile

Featured Publications